| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiation Injuries, Experimental | 19 | 2011 | 82 | 1.570 |
Why?
|
| Pulmonary Fibrosis | 14 | 2007 | 175 | 1.280 |
Why?
|
| Faculty, Medical | 5 | 2022 | 308 | 1.250 |
Why?
|
| Academic Medical Centers | 3 | 2022 | 690 | 1.090 |
Why?
|
| Lung | 34 | 2011 | 3293 | 1.010 |
Why?
|
| Mice, Inbred C3H | 31 | 2009 | 407 | 0.860 |
Why?
|
| Radiation Pneumonitis | 9 | 2011 | 313 | 0.860 |
Why?
|
| Staff Development | 2 | 2018 | 62 | 0.740 |
Why?
|
| Medicine | 1 | 2022 | 140 | 0.710 |
Why?
|
| Mentors | 2 | 2018 | 203 | 0.640 |
Why?
|
| Dose-Response Relationship, Radiation | 24 | 2001 | 751 | 0.550 |
Why?
|
| Bleomycin | 8 | 2007 | 482 | 0.550 |
Why?
|
| Colon | 5 | 1998 | 690 | 0.530 |
Why?
|
| Women, Working | 1 | 2013 | 15 | 0.460 |
Why?
|
| Career Mobility | 2 | 2016 | 89 | 0.450 |
Why?
|
| Sexism | 3 | 2019 | 54 | 0.450 |
Why?
|
| Leadership | 4 | 2022 | 261 | 0.420 |
Why?
|
| Radiation Injuries | 7 | 2007 | 1472 | 0.420 |
Why?
|
| Physicians, Women | 4 | 2019 | 99 | 0.400 |
Why?
|
| Interprofessional Relations | 1 | 2013 | 210 | 0.390 |
Why?
|
| Rectum | 3 | 1998 | 479 | 0.390 |
Why?
|
| Respiration | 10 | 2004 | 465 | 0.390 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2011 | 68 | 0.380 |
Why?
|
| Radiotherapy | 11 | 2011 | 1858 | 0.380 |
Why?
|
| Mice | 64 | 2011 | 36006 | 0.360 |
Why?
|
| Jejunum | 7 | 2003 | 234 | 0.340 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2002 | 126 | 0.340 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2011 | 257 | 0.330 |
Why?
|
| Animals | 77 | 2011 | 62757 | 0.300 |
Why?
|
| Radiation-Protective Agents | 5 | 2005 | 129 | 0.300 |
Why?
|
| Schools, Medical | 2 | 2022 | 132 | 0.290 |
Why?
|
| Lung Compliance | 1 | 2007 | 26 | 0.290 |
Why?
|
| Fibroblasts | 4 | 2011 | 1669 | 0.280 |
Why?
|
| Radiation-Sensitizing Agents | 6 | 1997 | 366 | 0.250 |
Why?
|
| H-2 Antigens | 1 | 2004 | 42 | 0.250 |
Why?
|
| Radiation Tolerance | 9 | 2007 | 636 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 17 | 2011 | 7222 | 0.240 |
Why?
|
| Genes, MHC Class II | 1 | 2004 | 71 | 0.240 |
Why?
|
| Salaries and Fringe Benefits | 2 | 2022 | 47 | 0.240 |
Why?
|
| Amifostine | 3 | 2005 | 99 | 0.230 |
Why?
|
| Major Histocompatibility Complex | 2 | 2009 | 98 | 0.230 |
Why?
|
| Pneumonia | 7 | 1995 | 798 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 4 | 2011 | 1133 | 0.230 |
Why?
|
| Razoxane | 1 | 2003 | 22 | 0.220 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2006 | 744 | 0.220 |
Why?
|
| Jejunal Diseases | 1 | 2003 | 25 | 0.220 |
Why?
|
| Protective Agents | 1 | 2003 | 51 | 0.210 |
Why?
|
| Superoxide Dismutase | 6 | 2001 | 269 | 0.210 |
Why?
|
| Whole-Body Irradiation | 6 | 1993 | 324 | 0.200 |
Why?
|
| Chromosome Mapping | 3 | 2002 | 1650 | 0.190 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 265 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2009 | 5744 | 0.190 |
Why?
|
| Intestinal Obstruction | 3 | 1998 | 224 | 0.180 |
Why?
|
| Mice, Inbred Strains | 7 | 2007 | 570 | 0.170 |
Why?
|
| Women's Rights | 1 | 2019 | 4 | 0.170 |
Why?
|
| Cyclophosphamide | 3 | 1992 | 3231 | 0.170 |
Why?
|
| Bone Marrow | 6 | 2007 | 2431 | 0.170 |
Why?
|
| DNA Repair | 4 | 1993 | 1912 | 0.160 |
Why?
|
| Rectal Diseases | 1 | 1998 | 57 | 0.150 |
Why?
|
| Sexual Harassment | 1 | 2018 | 21 | 0.150 |
Why?
|
| Cobalt Radioisotopes | 1 | 1997 | 41 | 0.150 |
Why?
|
| Colonic Diseases | 1 | 1998 | 74 | 0.150 |
Why?
|
| Time Factors | 24 | 2007 | 13116 | 0.150 |
Why?
|
| Camptothecin | 2 | 1997 | 538 | 0.150 |
Why?
|
| Species Specificity | 5 | 2000 | 810 | 0.150 |
Why?
|
| Sex Offenses | 1 | 2018 | 50 | 0.140 |
Why?
|
| Lethal Dose 50 | 7 | 1997 | 38 | 0.140 |
Why?
|
| Skin | 2 | 1995 | 1284 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2007 | 7788 | 0.140 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 1997 | 557 | 0.140 |
Why?
|
| Doxorubicin | 2 | 2003 | 3131 | 0.140 |
Why?
|
| Mice, Congenic | 3 | 2009 | 31 | 0.140 |
Why?
|
| X-Ray Film | 1 | 1996 | 31 | 0.130 |
Why?
|
| Models, Biological | 6 | 2002 | 3223 | 0.130 |
Why?
|
| Models, Theoretical | 2 | 2018 | 809 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 184 | 0.130 |
Why?
|
| Iridium Radioisotopes | 1 | 1996 | 57 | 0.130 |
Why?
|
| Aloe | 1 | 1995 | 7 | 0.130 |
Why?
|
| Radiation Genetics | 2 | 1993 | 5 | 0.130 |
Why?
|
| Plants, Medicinal | 1 | 1995 | 48 | 0.130 |
Why?
|
| Regeneration | 1 | 1998 | 286 | 0.120 |
Why?
|
| Digestive System | 3 | 1992 | 121 | 0.120 |
Why?
|
| Radiation Dosage | 9 | 1998 | 1043 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1995 | 243 | 0.120 |
Why?
|
| Male | 38 | 2018 | 128836 | 0.110 |
Why?
|
| Education, Medical | 1 | 2018 | 344 | 0.110 |
Why?
|
| Cell Survival | 8 | 2003 | 3075 | 0.110 |
Why?
|
| Female | 33 | 2019 | 148992 | 0.110 |
Why?
|
| Collagen | 2 | 1995 | 737 | 0.110 |
Why?
|
| Oxygen | 4 | 1986 | 800 | 0.100 |
Why?
|
| Premedication | 1 | 1992 | 133 | 0.100 |
Why?
|
| Career Choice | 1 | 2013 | 206 | 0.100 |
Why?
|
| Indomethacin | 1 | 1992 | 114 | 0.100 |
Why?
|
| Inflammation | 4 | 2009 | 2532 | 0.100 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2011 | 53 | 0.100 |
Why?
|
| Kidney | 5 | 1994 | 2265 | 0.090 |
Why?
|
| Radiotherapy Dosage | 7 | 2005 | 4003 | 0.090 |
Why?
|
| S100 Proteins | 1 | 2011 | 190 | 0.090 |
Why?
|
| Fibrosis | 3 | 2007 | 746 | 0.090 |
Why?
|
| Hematopoietic System | 2 | 1992 | 26 | 0.090 |
Why?
|
| Humans | 32 | 2022 | 271636 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 192 | 0.090 |
Why?
|
| Radiometry | 1 | 1996 | 1017 | 0.090 |
Why?
|
| Ozone | 1 | 2009 | 30 | 0.090 |
Why?
|
| Nitroimidazoles | 2 | 1982 | 107 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 718 | 0.080 |
Why?
|
| Gene Expression | 3 | 1999 | 3688 | 0.080 |
Why?
|
| Genetic Therapy | 5 | 2001 | 1732 | 0.080 |
Why?
|
| Misonidazole | 3 | 1985 | 11 | 0.080 |
Why?
|
| Brachytherapy | 1 | 1996 | 1005 | 0.080 |
Why?
|
| Organothiophosphorus Compounds | 1 | 1988 | 6 | 0.080 |
Why?
|
| Genetic Linkage | 2 | 2002 | 601 | 0.080 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 1997 | 107 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 3 | 1991 | 1773 | 0.080 |
Why?
|
| Neon | 1 | 1987 | 1 | 0.080 |
Why?
|
| DNA Damage | 3 | 2005 | 1989 | 0.080 |
Why?
|
| Radiobiology | 2 | 2003 | 56 | 0.070 |
Why?
|
| Serum Amyloid P-Component | 1 | 2007 | 31 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 43 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 2 | 2007 | 209 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 2 | 2001 | 427 | 0.070 |
Why?
|
| Haemophilus influenzae | 1 | 2007 | 161 | 0.070 |
Why?
|
| Organ Specificity | 1 | 1989 | 754 | 0.070 |
Why?
|
| Tidal Volume | 1 | 2007 | 58 | 0.070 |
Why?
|
| United States | 2 | 2022 | 16036 | 0.070 |
Why?
|
| Disease Susceptibility | 3 | 1998 | 544 | 0.070 |
Why?
|
| Spinal Cord | 3 | 1989 | 724 | 0.070 |
Why?
|
| Selenium | 2 | 1986 | 51 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2007 | 758 | 0.060 |
Why?
|
| Mutagenicity Tests | 1 | 2005 | 70 | 0.060 |
Why?
|
| Plethysmography, Whole Body | 3 | 1990 | 8 | 0.060 |
Why?
|
| Radiation | 1 | 2003 | 19 | 0.060 |
Why?
|
| Phenotype | 4 | 2007 | 6510 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2007 | 529 | 0.060 |
Why?
|
| Science | 1 | 2003 | 38 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2011 | 5838 | 0.050 |
Why?
|
| Common Bile Duct | 1 | 1982 | 28 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2007 | 4370 | 0.050 |
Why?
|
| Intestinal Mucosa | 4 | 1998 | 1125 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 280 | 0.050 |
Why?
|
| Gamma Rays | 3 | 1994 | 241 | 0.050 |
Why?
|
| Paralysis | 1 | 1982 | 55 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 882 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 1992 | 404 | 0.050 |
Why?
|
| Vitamin E | 1 | 1982 | 131 | 0.050 |
Why?
|
| Idarubicin | 1 | 2003 | 459 | 0.050 |
Why?
|
| Transgenes | 2 | 2000 | 589 | 0.040 |
Why?
|
| Probability | 2 | 2001 | 887 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2002 | 434 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 1707 | 0.040 |
Why?
|
| Lymphoma | 2 | 2007 | 1514 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2007 | 7463 | 0.040 |
Why?
|
| Drug Administration Schedule | 3 | 2007 | 3538 | 0.040 |
Why?
|
| Liver | 4 | 1986 | 3123 | 0.040 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 1999 | 17 | 0.040 |
Why?
|
| Kinetics | 3 | 1989 | 2242 | 0.040 |
Why?
|
| Mesenteric Arteries | 1 | 1979 | 66 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2019 | 80 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2007 | 1060 | 0.040 |
Why?
|
| Genome | 1 | 2002 | 690 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 2495 | 0.040 |
Why?
|
| Mesenteric Veins | 1 | 1979 | 83 | 0.040 |
Why?
|
| Radiation Oncology | 1 | 2003 | 557 | 0.040 |
Why?
|
| Neural Conduction | 1 | 1978 | 113 | 0.040 |
Why?
|
| Combined Modality Therapy | 6 | 2005 | 9042 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2018 | 78 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 2624 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 1997 | 257 | 0.040 |
Why?
|
| Rats | 6 | 2007 | 6633 | 0.040 |
Why?
|
| Liposomes | 4 | 2001 | 710 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 123 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2018 | 118 | 0.040 |
Why?
|
| Mesenchymoma | 1 | 1976 | 14 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 5180 | 0.040 |
Why?
|
| RNA, Messenger | 4 | 2001 | 6488 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 2 | 1994 | 100 | 0.030 |
Why?
|
| X-Rays | 2 | 1990 | 153 | 0.030 |
Why?
|
| Interleukin-1 | 2 | 1999 | 477 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2009 | 1613 | 0.030 |
Why?
|
| Radiography | 3 | 1998 | 1991 | 0.030 |
Why?
|
| Adenoviridae | 2 | 1999 | 1510 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 1995 | 9 | 0.030 |
Why?
|
| Lung Neoplasms | 4 | 2005 | 12008 | 0.030 |
Why?
|
| Nurseries, Hospital | 1 | 1975 | 7 | 0.030 |
Why?
|
| Myocardium | 1 | 1982 | 1251 | 0.030 |
Why?
|
| Cesium Radioisotopes | 1 | 1995 | 38 | 0.030 |
Why?
|
| Tensile Strength | 1 | 1995 | 74 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 1997 | 629 | 0.030 |
Why?
|
| Algorithms | 1 | 2007 | 3922 | 0.030 |
Why?
|
| Epithelium | 1 | 1998 | 805 | 0.030 |
Why?
|
| Leukocytes | 2 | 2007 | 426 | 0.030 |
Why?
|
| Gels | 1 | 1995 | 113 | 0.030 |
Why?
|
| Sex Factors | 2 | 1996 | 2202 | 0.030 |
Why?
|
| X Chromosome | 1 | 1996 | 402 | 0.030 |
Why?
|
| Radiation Protection | 1 | 1975 | 205 | 0.030 |
Why?
|
| Hematocrit | 1 | 1994 | 155 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 1997 | 14653 | 0.030 |
Why?
|
| Quality Control | 1 | 1996 | 467 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1062 | 0.030 |
Why?
|
| Thoracic Neoplasms | 1 | 1976 | 347 | 0.030 |
Why?
|
| Anaphylaxis | 1 | 1994 | 123 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2011 | 12219 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 5328 | 0.030 |
Why?
|
| Plasmids | 3 | 2001 | 953 | 0.030 |
Why?
|
| Mice, Inbred CBA | 3 | 1986 | 83 | 0.030 |
Why?
|
| Students, Medical | 1 | 2018 | 419 | 0.030 |
Why?
|
| Cell Division | 2 | 1990 | 2711 | 0.030 |
Why?
|
| Mice, SCID | 1 | 1996 | 1851 | 0.030 |
Why?
|
| Contracture | 1 | 1992 | 35 | 0.020 |
Why?
|
| Wound Healing | 2 | 1995 | 758 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2019 | 801 | 0.020 |
Why?
|
| Hair Follicle | 1 | 1992 | 63 | 0.020 |
Why?
|
| Abdomen | 2 | 1993 | 348 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2018 | 1349 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1994 | 318 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1997 | 5102 | 0.020 |
Why?
|
| Dogs | 5 | 1983 | 1169 | 0.020 |
Why?
|
| Intubation, Intratracheal | 2 | 2007 | 454 | 0.020 |
Why?
|
| Radiotherapy, High-Energy | 3 | 1983 | 303 | 0.020 |
Why?
|
| Embryo, Mammalian | 2 | 2007 | 756 | 0.020 |
Why?
|
| Leg | 1 | 1992 | 216 | 0.020 |
Why?
|
| Tooth Abnormalities | 1 | 1990 | 14 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2006 | 917 | 0.020 |
Why?
|
| Lymphotoxin-alpha | 1 | 2009 | 26 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 1996 | 1330 | 0.020 |
Why?
|
| Lung Diseases | 2 | 1999 | 755 | 0.020 |
Why?
|
| Nephrectomy | 1 | 1994 | 808 | 0.020 |
Why?
|
| Genotype | 1 | 1997 | 4263 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2009 | 191 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1994 | 731 | 0.020 |
Why?
|
| Pulmonary Alveoli | 2 | 2001 | 223 | 0.020 |
Why?
|
| Trachea | 2 | 2001 | 290 | 0.020 |
Why?
|
| Injections | 2 | 2000 | 288 | 0.020 |
Why?
|
| Risk Factors | 2 | 2003 | 18016 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1990 | 738 | 0.020 |
Why?
|
| Absorptiometry, Photon | 2 | 2001 | 237 | 0.020 |
Why?
|
| Multigene Family | 1 | 2009 | 465 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 1998 | 7817 | 0.020 |
Why?
|
| Ions | 1 | 1987 | 58 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 2004 | 238 | 0.020 |
Why?
|
| Uteroglobin | 1 | 2007 | 77 | 0.020 |
Why?
|
| Rubella | 1 | 1967 | 24 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 5856 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 2252 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1992 | 1372 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 5566 | 0.020 |
Why?
|
| Linear Models | 1 | 1990 | 1100 | 0.020 |
Why?
|
| Apoptosis | 2 | 2007 | 7834 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 269 | 0.020 |
Why?
|
| Microcomputers | 1 | 2006 | 36 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2006 | 97 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2018 | 1435 | 0.020 |
Why?
|
| Cell Line | 2 | 2007 | 5431 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 524 | 0.020 |
Why?
|
| Mucins | 1 | 2007 | 289 | 0.020 |
Why?
|
| Vitamin E Deficiency | 1 | 1986 | 5 | 0.020 |
Why?
|
| Metaplasia | 1 | 2007 | 386 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 1990 | 790 | 0.020 |
Why?
|
| Glutathione Peroxidase | 2 | 1986 | 64 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1986 | 163 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1992 | 2365 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 1993 | 2468 | 0.020 |
Why?
|
| Retroperitoneal Space | 2 | 1983 | 156 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 1986 | 68 | 0.020 |
Why?
|
| Cytosol | 2 | 1986 | 271 | 0.020 |
Why?
|
| Survival Rate | 2 | 2003 | 12530 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 876 | 0.020 |
Why?
|
| Cytokines | 2 | 2007 | 2837 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1986 | 331 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1986 | 355 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2001 | 3651 | 0.010 |
Why?
|
| Intestines | 1 | 1989 | 729 | 0.010 |
Why?
|
| Pulmonary Ventilation | 1 | 2004 | 49 | 0.010 |
Why?
|
| Cisplatin | 2 | 1989 | 2497 | 0.010 |
Why?
|
| Esophagitis | 1 | 2005 | 210 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2007 | 607 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2005 | 16606 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2003 | 60 | 0.010 |
Why?
|
| Neoplasms | 1 | 1990 | 15903 | 0.010 |
Why?
|
| Cerebellum | 1 | 2007 | 477 | 0.010 |
Why?
|
| Mitosis | 1 | 1986 | 692 | 0.010 |
Why?
|
| Hyperthermia, Induced | 1 | 1988 | 510 | 0.010 |
Why?
|
| Transfusion Reaction | 1 | 2003 | 101 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2007 | 1396 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 1999 | 1883 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2003 | 168 | 0.010 |
Why?
|
| Fibrosarcoma | 2 | 1988 | 142 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1983 | 151 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1990 | 5804 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 1666 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 1982 | 49 | 0.010 |
Why?
|
| Genomic Instability | 1 | 2005 | 522 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1983 | 274 | 0.010 |
Why?
|
| Duodenum | 1 | 1982 | 170 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 1983 | 249 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 1982 | 257 | 0.010 |
Why?
|
| Surface-Active Agents | 1 | 2001 | 41 | 0.010 |
Why?
|
| Research | 1 | 2003 | 431 | 0.010 |
Why?
|
| Mice, Nude | 2 | 1999 | 4358 | 0.010 |
Why?
|
| Comet Assay | 1 | 2000 | 57 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 1568 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1983 | 299 | 0.010 |
Why?
|
| Genes, ras | 1 | 2004 | 681 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1992 | 9323 | 0.010 |
Why?
|
| Cholestasis | 1 | 1982 | 206 | 0.010 |
Why?
|
| Portal Vein | 1 | 1982 | 364 | 0.010 |
Why?
|
| Cell Movement | 1 | 2007 | 2503 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1983 | 526 | 0.010 |
Why?
|
| Aorta | 1 | 1983 | 683 | 0.010 |
Why?
|
| Bronchi | 1 | 2001 | 330 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1982 | 357 | 0.010 |
Why?
|
| Strontium Radioisotopes | 1 | 1979 | 31 | 0.010 |
Why?
|
| Organ Size | 1 | 1981 | 727 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1979 | 65 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1978 | 58 | 0.010 |
Why?
|
| Intraoperative Period | 3 | 1983 | 259 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1979 | 116 | 0.010 |
Why?
|
| Endothelium | 1 | 1979 | 162 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 2471 | 0.010 |
Why?
|
| Disease Management | 1 | 2003 | 1111 | 0.010 |
Why?
|
| Curriculum | 1 | 2003 | 910 | 0.010 |
Why?
|
| Electrons | 1 | 1979 | 187 | 0.010 |
Why?
|
| Lung Injury | 1 | 1999 | 145 | 0.010 |
Why?
|
| Pulmonary Emphysema | 1 | 1999 | 157 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1979 | 543 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1998 | 910 | 0.010 |
Why?
|
| Body Weight | 1 | 1981 | 1334 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2000 | 1011 | 0.010 |
Why?
|
| Heart | 1 | 1982 | 1214 | 0.010 |
Why?
|
| Recurrence | 1 | 2003 | 4884 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1975 | 89 | 0.010 |
Why?
|
| Histamine Release | 1 | 1994 | 15 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1994 | 112 | 0.010 |
Why?
|
| Action Potentials | 1 | 1978 | 596 | 0.010 |
Why?
|
| Trichinella spiralis | 1 | 1994 | 24 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 3670 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2000 | 2150 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1976 | 213 | 0.010 |
Why?
|
| Chlorides | 1 | 1994 | 139 | 0.010 |
Why?
|
| Morbidity | 1 | 1995 | 404 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2000 | 1157 | 0.010 |
Why?
|
| Antigens | 1 | 1994 | 283 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1994 | 181 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1994 | 364 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 3262 | 0.010 |
Why?
|
| Thorax | 1 | 1995 | 230 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1995 | 474 | 0.010 |
Why?
|
| Mast Cells | 1 | 1994 | 231 | 0.010 |
Why?
|
| Sarcoma | 1 | 1983 | 1842 | 0.010 |
Why?
|
| Aging | 1 | 1981 | 1578 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 5779 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 3088 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1976 | 694 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 3512 | 0.010 |
Why?
|
| Mortality | 1 | 1993 | 353 | 0.010 |
Why?
|
| Middle Aged | 4 | 2005 | 90349 | 0.010 |
Why?
|
| Leukemia P388 | 1 | 1990 | 28 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1998 | 5113 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1990 | 532 | 0.000 |
Why?
|
| Hematologic Diseases | 1 | 1990 | 255 | 0.000 |
Why?
|
| Rupture | 1 | 1968 | 56 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2003 | 5688 | 0.000 |
Why?
|
| Aged | 3 | 2005 | 73421 | 0.000 |
Why?
|
| Urethra | 1 | 1968 | 167 | 0.000 |
Why?
|
| Adult | 3 | 2005 | 81791 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2001 | 13385 | 0.000 |
Why?
|
| Anemia, Aplastic | 1 | 1988 | 233 | 0.000 |
Why?
|
| Necrosis | 1 | 1988 | 604 | 0.000 |
Why?
|
| Catalase | 1 | 1986 | 75 | 0.000 |
Why?
|
| Subcellular Fractions | 1 | 1986 | 212 | 0.000 |
Why?
|
| Creatinine | 1 | 1988 | 546 | 0.000 |
Why?
|
| Clinical Trials as Topic | 2 | 1988 | 3852 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 7971 | 0.000 |
Why?
|
| Glutathione Transferase | 1 | 1986 | 371 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1988 | 433 | 0.000 |
Why?
|
| Spleen | 1 | 1986 | 732 | 0.000 |
Why?
|
| Mutation | 1 | 2004 | 15913 | 0.000 |
Why?
|
| Autoradiography | 1 | 1983 | 158 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1986 | 347 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1975 | 8587 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1988 | 789 | 0.000 |
Why?
|
| Arteries | 1 | 1982 | 294 | 0.000 |
Why?
|
| Research Design | 1 | 1988 | 1580 | 0.000 |
Why?
|
| Particle Accelerators | 1 | 1983 | 362 | 0.000 |
Why?
|
| Ureter | 1 | 1982 | 227 | 0.000 |
Why?
|
| Leukemia | 1 | 1988 | 1721 | 0.000 |
Why?
|
| Diet | 1 | 1986 | 1489 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1976 | 16226 | 0.000 |
Why?
|
| Stomach Neoplasms | 1 | 1983 | 2317 | 0.000 |
Why?
|
| Child | 1 | 1968 | 30401 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1983 | 4805 | 0.000 |
Why?
|
| Adolescent | 1 | 1983 | 32609 | 0.000 |
Why?
|